Review ofthe Emerging Evidence Demonstrating the Efficacy of Ivermectin in theProphylaxis and Treatment of COVID-19
Pierre Kory, MD, 1,*Gianfranco Umberto Meduri, MD, 2 Joseph Varon, MD, 3 Jose Iglesias, DO, 4 andPaul E. Marik,MD 5
Author informationCopyright and License information Disclaimer
American Journal of Therapeutics. 2021May-Jun; 28(3): e299–e318.
Publishedonline 2021 Apr 22Conclusions:
Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductionsin mortality, time to clinical recovery, and time to viral clearance.
Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088823/
- Forums
- Political Debate
- Ivermectin
Ivermectin, page-472
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online